Sentiment Trading

MediWound Ltd. reported mixed earnings, but its research developments, including a promising study on wound bed preparation and new Phase II data for its EscharEx product, offer a positive outlook for future growth.

MediWound Ltd. is set to release its Q1 2025 financials on May 21, 2025, with analysts projecting a loss per share but a 4.84% revenue increase, amidst a promising outlook for the global burn care market.